Tuesday - January 13, 2026

Nipocalimab Market Size Forecast and Emerging Insights Signal Strong Growth Outlook Through 2034, estimates DelveInsight

Nipocalimab Market Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren’s syndrome, Systemic lupus erythematosus and others. The Nipocalimab market is entering a pivotal growth phase, driven by recent … Continue reading

Graft Versus Host Disease Market Projected to Attain USD 3,304 Million by 2034, Estimates DelveInsight

Graft Versus Host Disease Market GvHD companies include Medac, MaaT Pharma, ElsaLys Biotech (Mediolanum Farmaceutici Spa), Syndax Pharmaceuticals, Kadmon Corporation, AstraZeneca, Biogen, Amgen, Pfizer, AltruBio, CSL Behring, Incyte Corporation, Takeda, OncoImmune, Merck (MSD), Regimmune Corporation, Jazz Pharmaceuticals, Millennium Pharmaceuticals, Takeda … Continue reading